SIRPα's role in heart enlargement and muscle wasting in chronic kidney disease

Chronic Kidney Disease-Induced Defects Initiated by SIRPα

NIH-funded research Michael E Debakey VA Medical Center · NIH-11129650

This research looks at whether a protein called SIRPα causes muscle wasting and harmful heart growth in adults with chronic kidney disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMichael E Debakey VA Medical Center NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11129650 on NIH RePORTER

What this research studies

From the patient perspective, researchers will measure SIRPα, inflammation, and insulin/IGF1 signaling in heart, muscle, fat tissue, and blood from people and laboratory models with chronic kidney disease. They will compare patient samples to controls and run lab experiments to see how changes in SIRPα drive muscle loss (cachexia) versus increased heart muscle mass. The work combines human tissue or blood analyses with cell and animal experiments to link molecular changes to real heart and muscle effects. The goal is to explain why CKD causes wasting in skeletal muscle and growth in the heart so better treatments can be developed.

Who could benefit from this research

Good fit: Adults with chronic kidney disease, especially those with muscle loss (cachexia) or evidence of heart enlargement, would be the most relevant candidates.

Not a fit: People without chronic kidney disease, children, or patients whose symptoms are driven by pathways unrelated to SIRPα are unlikely to receive direct benefit from this project.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or treat muscle wasting and dangerous heart changes in people with CKD.

How similar studies have performed: Prior work has shown SIRPα is linked to insulin resistance and muscle wasting in CKD, but using that insight to explain and prevent CKD-related heart remodeling is a newer direction.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.